Patients taking semaglutide at 0.5 mg/wk subcutaneously (SC) should transition to 7 mg or 14 mg orally starting up to 7 days after their last injection. The initial dose of oral semaglutide is 3 mg/d for 30 days. The 3-mg dose is intended for treatment initiation and is not effective for glycemic control. After 30 days on 7 mg/d, patients may increase dose to 14 mg/d if additional glycemic control is needed; however, taking two 7-mg tablets to achieve 14 mg dose is not recommended. Oral semaglutide is not recommended as a first-line therapy for patients who have inadequate glycemic control on diet and exercise.
Learn more about semaglutide.
Medscape © 2022 WebMD, LLC
Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.
Cite this: Mary L. Windle. Rapid Rx Quiz: Diabetes Drugs - Medscape - May 13, 2022.